ABOS LongAcumen Pharmaceuticals, Inc. is gearing up for a big move, and it looks like it's about to break through some important levels. As the stock gets ready to cross a low volume node, we could see it shoot up toward higher targets. They’ve got some exciting news coming up, too—a late-breaking presentati